Regular STI Screening May Reduce Incidence Of Chlamydia But Not Gonorrhea In MSM, Transgender Women On HIV PrEP, Study Finds

Infectious Disease Advisor (5/20, Nye) reports, “Screening for Neisseria gonorrhoeae and Chlamydia trachomatis at 3 anatomical sites every 3 months may reduce the incidence of chlamydia but not gonorrhea in men who have sex with men (MSM) and transgender women receiving HIV pre-exposure prophylaxis (PrEP). These study results were published in The Lancet HIV.”